C12Q 2565/20
Detection means characterised by being a gene reporter based analysis
C12Q2565/20 (Detection means characterised by being a gene reporter based analysis) appears on 5 US grants and 4 published applications in this corpus.
Search patents in C12Q- Granted patents
- 5
- Published applications
- 4
- Assignees
- 6
- Inventors
- 15
- Latest grant
- 16 Oct 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Materials and methods for detecting interaction of CFTR polypeptides16 Oct 2012US 8,288,107 B2The Florida State University Research Foundation, Inc.
- Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins22 Feb 2011US 7,892,772 B2ITI Scotland Limited
- Materials and methods for detecting interaction of CFTR polypeptides3 Jul 2007US 7,238,474 B1The Florida State University Research Foundation, Inc.
- Mammalian protein interaction cloning system13 Nov 2001US 6,316,223 B1Rigel Pharmaceuticals, Inc.
- Mammalian protein interaction cloning system5 Sep 2000US 6,114,111 ARigel Pharmaceuticals, Inc.
- Predicting cancer relapse and treatment of cancer diseases28 Sep 2023US 2023/0304097 A1
- Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins23 Oct 2008US 2008/0261241 A1Institut Nat De La Sante Et De La Recherche Med
- Materials and methods for detecting interaction of CFTR polypeptides10 Jul 2008US 2008/0167259 A1The Florida State University Research Foundation, Inc.
- High throughput one-hybrid system21 Dec 2006US 2006/0286600 A1
Most cited
By later US patents
- Mammalian protein interaction cloning system15US 6,316,223 B1Rigel Pharmaceuticals, Inc. · 2001
- Mammalian protein interaction cloning system12US 6,114,111 ARigel Pharmaceuticals, Inc. · 2000
- Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins2US 7,892,772 B2ITI Scotland Limited · 2011